Home › Funds › Tri Locum Partners LP › VRDN

Tri Locum Partners LP position in VRDN

VIRIDIAN THERAPEUTICS INC · Health Care

Tri Locum Partners LP reported holding 90,107 shares of VRDN (VIRIDIAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.37% of its reported portfolio and ranking #18 among its reported holdings. Tri Locum Partners LP first reported this position in Q3 2026.

Latest position (Q3 2026)90.11K sh
Reported value held$1.86M
Portfolio Weight0.37%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Tri Locum Partners LP's VRDN position evolved

Tri Locum Partners LP first disclosed a stake in VRDN in Q3 2026 at 90,107 shares (US$1.9M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 90.11K $1.86M New

About VRDN and 13F data

VRDN (VIRIDIAN THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in VRDN — the largest reported positions include Paradigm Biocapital Advisors LP (US$227.1M), Kynam Capital Management, LP (US$126.6M), Bellevue Group AG (US$123.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRDN

All VRDN fund holders →

FAQ

How long has Tri Locum Partners LP held VRDN?

Tri Locum Partners LP has disclosed VRDN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Tri Locum Partners LP's current position in VRDN?

As of Q3 2026, Tri Locum Partners LP holds 90.11K shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $1.86M, representing 0.37% of its reported portfolio and ranking #18.

Has Tri Locum Partners LP been buying or selling VRDN?

In the latest 13F filing (Q3 2026), Tri Locum Partners LP newly opened its position in VRDN.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, Bellevue Group AG, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.